Gliosarcoma - Pipeline Review, H1 2012 - New Market Report Now Available
Reasons to Get this ReportGlobal Markets Direct's, 'Gliosarcoma - Pipeline Review, H1 2012', provides an overview of the Gliosarcoma therapeutic pipeline. This report provides information on the therapeutic development for Gliosarcoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Gliosarcoma. 'Gliosarcoma - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations...
View full press release